Invention Grant
- Patent Title: Methods and compositions for in vivo induction of pancreatic beta cell formation
-
Application No.: US14418957Application Date: 2013-07-31
-
Publication No.: US09649344B2Publication Date: 2017-05-16
- Inventor: Bruno Doiron , Ralph A. DeFronzo
- Applicant: The Board of Regents of the University of Texas System
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Norton Rose Fulbright US LLP
- International Application: PCT/US2013/052820 WO 20130731
- International Announcement: WO2014/022455 WO 20140206
- Main IPC: A61K35/39
- IPC: A61K35/39 ; A61K31/7088 ; A61K38/17 ; A61K38/45 ; C12N15/113 ; C07K14/47 ; C12N9/12 ; C12N9/16 ; A61K48/00

Abstract:
Embodiments of the invention stimulate three levels of beta cell physiology: (i) glucose metabolism, (ii) membrane receptor function, and (iii) transcriptional factors that result in the in vivo formation of beta cells in the pancreas for the purpose of treating diabetes. In certain aspects, the methods include the integration of three levels of cellular physiology: metabolism, membrane receptor function, and gene transcription. The integration of multiple levels of cellular physiology produces a synergistic effect on beta cell formation.
Public/Granted literature
- US20150190432A1 Methods and Compositions for In Vivo Induction of Pancreatic Beta Cell Formation Public/Granted day:2015-07-09
Information query
IPC分类: